Chemoinformaics analysis of 9,12-Linoleic Methyl Ester (Z, Z)
| Molecular Weight | 294.479 | nRot | 14 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 3 |
| Exact Molecular Weight | 294.256 | nRing | 0 |
| Solubility: LogS | -3.643 | nHRing | 0 |
| Solubility: LogP | 5.022 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 56.005 |
| nHD | 0 | BPOL | 36.713 |
| QED | 0.224 |
| Synth | 2.313 |
| Natural Product Likeliness | 1.03 |
| NR-PPAR-gamma | 0.311 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.059 |
| CACO-2 | -4.858 |
| MDCK | 0.0000479 |
| BBB | 0.908 |
| PPB | 0.978753 |
| VDSS | 2.86 |
| FU | 0.016753 |
| CYP1A2-inh | 0.648 |
| CYP1A2-sub | 0.621 |
| CYP2c19-inh | 0.518 |
| CYP2c19-sub | 0.182 |
| CYP2c9-inh | 0.423 |
| CYP2c9-sub | 0.951 |
| CYP2d6-inh | 0.603 |
| CYP2d6-sub | 0.87 |
| CYP3a4-inh | 0.803 |
| CYP3a4-sub | 0.121 |
| CL | 5.396 |
| T12 | 0.913 |
| hERG | 0.167 |
| Ames | 0.225 |
| ROA | 0.036 |
| SkinSen | 0.961 |
| Carcinogencity | 0.352 |
| EI | 0.474 |
| Respiratory | 0.775 |
| NR-Aromatase | 0.081 |
| Antiviral | No |
| Prediction | 0.599226 |